Dr. Guru P. Sonpavde, MD
- Medicare services, 2024
- 541
- Medicare patients, 2024
- 173
- Part D claims, 2024
- 1,040
- Publications
- 429
- Clinical trials
- 29
- Practice address
- 601 E Rollins St, Orlando, FL 32803
- Practice phone
- Call (407) 303-1976
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Sonpavde's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Guru P. Sonpavde is a medical oncologist in Orlando, Florida
Dr. Sonpavde practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.
Dr. Sonpavde's NPI, 1083655716, was assigned on June 10, 2006. Dr. Sonpavde graduated from Christian Medical College Vellore in 1990. Dr. Sonpavde holds Florida license ME154902.
- NPI
- 1083655716NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7416946892
- NPI enumeration date
- June 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (407) 303-1976
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 62
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Guru P. Sonpavde practices at AdventHealth Orlando in Orlando, Florida
Dr. Sonpavde's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.
- AdventHealth Orlando601 E Rollins St, Orlando, FL 32803 · Orange CountyPhone(407) 303-1976
Source: Dmand AI Affiliation Data
Dr. Guru P. Sonpavde is affiliated with 4 sites of care and 1 medical group
Dr. Sonpavde's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Sonpavde is also affiliated with AdventHealth Waterman. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Sonpavde to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Guru P. Sonpavde's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sonpavde practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| AdventHealth Orlando | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across AdventHealth and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Guru P. Sonpavde is one of 477 medical oncologists in Florida
Medical oncology is Dr. Sonpavde's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Sonpavde is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Sonpavde's licenses on file in 10 states: Florida, Connecticut, Massachusetts, New Hampshire, Rhode Island, Alabama, Texas, Arizona, Tennessee and Indiana.
Specialties and state licenses
- Medical oncology, FloridaPrimary
- Connecticut license
- Hematology (internal medicine), Massachusetts
- New Hampshire license
- Rhode Island license
- Alabama license
- Hematology and oncology, Texas
- Arizona license
- Tennessee license
- Indiana license
Clinical focus
Dmand AI lists prostate cancer among the conditions Dr. Sonpavde treats.
Medical oncologists near Dr. Sonpavde
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Guru P. Sonpavde billed Medicare for 541 services in 2024
CMS data shows 541 Medicare services from Dr. Sonpavde across 6 procedure codes in 2024, for 173 Medicare patients. Medicare paid $36,810 for them. Every service was in an office.
Dr. Sonpavde's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4432024: 50815%
- Lab and pathology
- 2023: 212024: 3357%
Dr. Sonpavde compared with the Florida median for medical oncologists, 2024
- Dr. Sonpavde
- Florida median
- Medicare services
- 541vs 19,75597% below
- Medicare patients
- 173vs 54168% below
- Part D claims
- 894vs 59849% above
Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Sonpavde's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Sonpavde?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sonpavde and other medical oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Guru P. Sonpavde treated 173 Medicare patients in 2024, average age 74
CMS counts 173 Medicare patients who saw Dr. Sonpavde in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Sonpavde's median patient age at 72, with 12% women.
Dr. Sonpavde's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Sonpavde's Medicare patients by sex, 2024
- Women1810%
- Men15590%
Chronic conditions among Dr. Sonpavde's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Ischemic heart disease44%
- Arthritis36%
- Chronic kidney disease32%
- Diabetes32%
- Atrial fibrillation22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Sonpavde's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women12%
- Men87%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Guru P. Sonpavde wrote 1,040 Medicare Part D claims in 2024
In 2024, Dr. Sonpavde wrote 1,040 Medicare Part D claims for 144 patients. 87% of them were for generic drugs. CMS names the drug for 894 of them, across 12 drugs with 11 or more claims each, at $1,632,918 in total drug cost. In 2023, CMS named 316 claims across 6 drugs.
Dr. Sonpavde's Part D claims by kind of drug, 2024
- Generic900 claims87%
- Brand-name140 claims13%
Dr. Sonpavde's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Sonpavde's Part D claims, 2024
- Opioids3%35 of 1,040 claims
- Antibiotics1%13 of 1,040 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3162024: 894183%
Drugs named by CMS: 12 in 2024, 6 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Guru P. Sonpavde offers telehealth to Medicare patients
Dr. Sonpavde accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sonpavde as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Guru P. Sonpavde has 429 publications on record
Dmand AI links 429 papers to Dr. Sonpavde, published from 2006 to 2025. 2021 was the busiest year, with 27. The most frequent topics are Urinary Bladder Neoplasms, Carcinoma, Transitional Cell and Antineoplastic Agents. Dr. Sonpavde has published most often in Clin Genitourin Cancer. Dr. Sonpavde's most frequent co-authors are Matthew D. Galsky, MD, Toni K. Choueiri, MD and Thomas Edgar Hutson, DO, PharmD.
Dr. Sonpavde's papers by year, 2016 to 2025
Topics Dr. Sonpavde writes about most
- Urinary Bladder Neoplasms
- Carcinoma, Transitional Cell
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Urologic Neoplasms
- Prostatic Neoplasms
- Neoplasm Metastasis
- Kidney Neoplasms
Dr. Sonpavde's most frequent co-authors
- Matthew D. Galsky, MD68 shared papers
- Toni K. Choueiri, MD58 shared papers
- Thomas Edgar Hutson, DO, PharmD28 shared papers
Recent publications by Dr. Sonpavde
See who Dr. Sonpavde researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sonpavde works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Guru P. Sonpavde has worked on 29 clinical trials
Dmand AI links Dr. Sonpavde to 29 clinical trials, 16 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Urinary Bladder Neoplasms and Prostatic Diseases. University of Alabama at Birmingham sponsors the most, 5. Open Payments lists research payments to Dr. Sonpavde that name 3 trials.
Clinical trials with Dr. Sonpavde by phase
- 5Phase 1: 5 trials
- 5Phase 1/2: 5 trials
- 16Phase 2: 16 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Sonpavde's trials
- Prostatic Neoplasms
- Urinary Bladder Neoplasms
- Prostatic Diseases
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
Investigators on the most trials with Dr. Sonpavde
- Ralph J. Hauke, MD4 shared trials
- Thomas Edgar Hutson, DO, PharmD3 shared trials
- Lisle M. Nabell3 shared trials
Recent clinical trials with Dr. Sonpavde
Sacituzumab Govitecan Plus EV in Metastatic UC (opens in a new tab)
Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients (opens in a new tab)
Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma (opens in a new tab)
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Guru P. Sonpavde received $547,408 in industry payments from 2016 to 2025
CMS Open Payments shows 594 general payments to Dr. Sonpavde from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Merck Sharp & Dohme Corporation paid the most, $130,185. It also lists 44 research payments totaling $27,357 from 2016 to 2025, naming 3 clinical trials.
General payments to Dr. Sonpavde by program year, 2016 to 2025
General payments to Dr. Sonpavde by kind, 2016 to 2025
- Consulting fees$315,67258%
- Speaker and faculty fees$128,11224%
- Travel and lodging$65,18012%
- Food and beverage$21,2904%
- Other$12,0602%
Companies that paid Dr. Sonpavde the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Guru P. Sonpavde graduated from Christian Medical College Vellore
Dr. Sonpavde graduated from Christian Medical College Vellore in 1990. Dr. Sonpavde is a member of ASCO.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Guru P. Sonpavde accepts plans from 20 insurance carriers
Dr. Sonpavde is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
- Elevance
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Cigna
- HCSC
- Humana
- +12 more carriersWith a free account
Plan types Dr. Sonpavde accepts, by number of carriers
- PPO12
- HMO11
- Medicare11
- POS6
- EPO5
- Medicaid3
Source: Dmand AI Insurance Network Data
Sources for Dr. Guru P. Sonpavde's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Guru P. Sonpavde
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Guru P. Sonpavde's NPI number?
Dr. Guru P. Sonpavde's NPI number is 1083655716. It was assigned on June 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Guru P. Sonpavde?
Dr. Guru P. Sonpavde is a medical oncologist in Orlando, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Guru P. Sonpavde practice?
Dr. Sonpavde practices at 601 E Rollins St, Orlando, FL 32803. Dr. Sonpavde's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dmand AI also links Dr. Sonpavde to 1 hospital and 1 group practice or clinic.
What is Dr. Guru P. Sonpavde's office phone number?
The practice phone on file for Dr. Sonpavde is (407) 303-1976.
What is Dr. Guru P. Sonpavde's medical license number?
Dr. Sonpavde holds Florida license ME154902, one of the licenses on file in 10 states.
Which states has Dr. Guru P. Sonpavde been licensed in?
Dmand AI has state licenses on file for Dr. Sonpavde in Florida (2022 to 2026), Connecticut, Massachusetts (2017 to 2024), New Hampshire (2024), Rhode Island (2020), Alabama (2012 to 2017), Texas (2003 to 2013), Arizona (2001 to 2003), Tennessee (1999 to 2002) and Indiana (1995 to 1999).
Which hospitals is Dr. Guru P. Sonpavde affiliated with?
Dr. Sonpavde practices at AdventHealth Orlando in Orlando, Florida. Dr. Sonpavde is also affiliated with AdventHealth Waterman. Dmand AI links Dr. Sonpavde to 1 more hospital.
What medical group is Dr. Guru P. Sonpavde part of?
Dr. Sonpavde is linked to AdventHealth Medical Group.
Does Dr. Guru P. Sonpavde accept Medicare?
Yes. CMS data shows Dr. Sonpavde billed Medicare for 541 services in 2024, and Dr. Sonpavde accepts Medicare assignment.
Does Dr. Guru P. Sonpavde offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Sonpavde as offering telehealth services.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Guru P. Sonpavde see?
CMS counts 173 Medicare patients who saw Dr. Sonpavde in 2024, with an average age of 74.
Is Dr. Guru P. Sonpavde board certified?
Yes. Dr. Sonpavde is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Guru P. Sonpavde bill to Medicare?
In 2024, Dr. Sonpavde's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99212) and office visit, established patient (99214).
Where did Dr. Guru P. Sonpavde go to medical school?
Dr. Sonpavde graduated from Christian Medical College Vellore in 1990.
What drugs does Dr. Guru P. Sonpavde prescribe most?
In 2024 Medicare Part D data, Dr. Sonpavde's most prescribed drugs by claims were Abiraterone Acetate, Alendronate Sodium and Prednisone.
Has Dr. Guru P. Sonpavde received payments from drug or device companies?
CMS Open Payments shows $547,408 in general payments to Dr. Sonpavde from 37 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Guru P. Sonpavde been practicing?
Dr. Sonpavde graduated from medical school in 1990, 36 years ago.
Does Dr. Guru P. Sonpavde do research?
Dmand AI links 429 publications to Dr. Sonpavde, published from 2006 to 2025. Dr. Sonpavde has worked on 29 clinical trials.
Who does Dr. Guru P. Sonpavde publish with?
Dr. Sonpavde's most frequent co-authors are Matthew D. Galsky, MD (68 shared papers), Toni K. Choueiri, MD (58 shared papers) and Thomas Edgar Hutson, DO, PharmD (28 shared papers).
What insurance does Dr. Guru P. Sonpavde accept?
Dr. Sonpavde is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card